Professor David Bowtell
Professor David Bowtell is an international expert and pioneer in genomics and personalised medicine. He is currently a Group Leader at the Peter MacCallum Cancer Centre. He will provide an invaluable resource in advising on the complementary use of genomics and molecular imaging to identify mechanisms of resistance to current cancer therapies and to develop novel treatment combinations to address this unmet need.
Professor Bowtell was Director of Research at the Peter MacCallum Cancer Centre for a decade from 2000-2009. He is currently the Principal Investigator for the Australian Ovarian Cancer Study (AOCS), one of the largest population-based cohort studies of ovarian cancer in the world and CASCADE, a rapid autopsy study.
David has made seminal discoveries relating to ovarian cancer classification, primary and acquired chemotherapy resistance, and factors influencing patient survival. His recent research has focused on the role of BRCA1/2 and related mutations in ovarian cancer genetic risk and therapeutic response, novel clinical trial design, and exceptional survival in ovarian cancer.He also has a longstanding interest in carcinoma of unknown primary origin.
David is a Fellow of the Australian Academy of Health and Medical Sciences and of the Australian Academy of Science.